Results 181 to 190 of about 153,159 (379)
Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease
Purpose: To report a case of pediatric Vogt-Koyanagi-Harada (VKH) successfully treated with infliximab and methotrexate for ten years. Observations: A 9-year-old Hispanic girl with VKH disease, was successfully treated with oral methotrexate 15 mg/week ...
Gustavo A. Budmann+2 more
doaj
Classification criteria for tubercular uveitis.
The Standardization Of Uveitis Nomenclature Sun Wo+12 more
semanticscholar +1 more source
Minimally Invasive Glaucoma Surgery: Is It Here to Stay?
ABSTRACT The advent of minimally invasive glaucoma surgery (MIGS) has expanded the treatment options available for glaucoma by providing options for reducing intraocular pressure without the serious complication profile associated with incisional glaucoma surgery.
Neeranjali Jain, Jennifer C. Fan Gaskin
wiley +1 more source
A chromosome study of patients with uveitis treated with chlorambucil. [PDF]
B.R. Reeves+4 more
openalex +1 more source
ABSTRACT Background We aimed to describe 1‐year outcomes of eyes switched to faricimab from first‐generation vascular endothelial growth factor (VEGF) inhibitors for neovascular age‐related macular degeneration (nAMD) in routine care. Methods Multicentre, observational study of 383 eyes tracked in the Fight Retinal Blindness!
Adrian Hunt+9 more
wiley +1 more source
Classification criteria for Fuchs uveitis syndrome.
The Standardization Of Uveitis Nomenclature Sun Working Group+11 more
semanticscholar +1 more source
We generated immune‐tolerant mature hESC‐RPE cells by overexpressing PD‐L1. PD‐L1‐expressing hESC‐RPE grafts exhibited significantly higher survival, reduced apoptosis and enhanced visual protection in retinal degeneration models, which presents an alternative target to improve the efficiency of hESC‐RPE‐based therapy for AMD. ABSTRACT Immune rejection
Bowen Li+11 more
wiley +1 more source
Microfilaria malayi in uveitis: case report. [PDF]
K Anandakannan, CP Gupta
openalex +1 more source